These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20617487)

  • 1. The hematocrit paradox--how does blood doping really work?
    Böning D; Maassen N; Pries A
    Int J Sports Med; 2011 Apr; 32(4):242-6. PubMed ID: 20617487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradox of hematocrit in exercise physiology: which is the "normal" range from an hemorheologist's viewpoint?
    Brun JF; Bouchahda C; Chaze D; Benhaddad AA; Micallef JP; Mercier J
    Clin Hemorheol Microcirc; 2000; 22(4):287-303. PubMed ID: 11081466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of erythropoietin on systemic hematocrit and oxygen transport in the splenectomized horse.
    McKeever KH; McNally BA; Hinchcliff KW; Lehnhard RA; Poole DC
    Respir Physiol Neurobiol; 2016 May; 225():38-47. PubMed ID: 26853328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biochemistry of drugs and doping methods used to enhance aerobic sport performance.
    Cooper CE
    Essays Biochem; 2008; 44():63-83. PubMed ID: 18384283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The new frontiers of blood doping].
    Lippi G; Franchini M
    Recenti Prog Med; 2002 Jan; 93(1):1-8. PubMed ID: 11850993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid.
    Sawka MN; Joyner MJ; Miles DS; Robertson RJ; Spriet LL; Young AJ
    Med Sci Sports Exerc; 1996 Jun; 28(6):i-viii. PubMed ID: 8926864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures for monitoring recombinant erythropoietin and analogs in doping.
    Lamon S; Robinson N; Saugy M
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):141-54, x. PubMed ID: 20122455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No proof for augmented arterial oxygen content as only factor influencing exercise capacity after Epo doping.
    Böning D; Maassen N; Pries A
    J Appl Physiol (1985); 2008 Dec; 105(6):1988; author reply 1989. PubMed ID: 19050342
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietin and analogs.
    Reichel C; Gmeiner G
    Handb Exp Pharmacol; 2010; (195):251-94. PubMed ID: 20020369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorheological correlates of fitness and unfitness in athletes: moving beyond the apparent "paradox of hematocrit"?
    Gaudard A; Varlet-Marie E; Bressolle F; Mercier J; Brun JF
    Clin Hemorheol Microcirc; 2003; 28(3):161-73. PubMed ID: 12775898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusion in sports.
    Giraud S; Sottas PE; Robinson N; Saugy M
    Handb Exp Pharmacol; 2010; (195):295-304. PubMed ID: 20020370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Point of view on doping].
    Naeije R; Pagnamenta A
    Rev Med Brux; 1999 Jun; 20(3):153-8. PubMed ID: 10429539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
    Robinson N; Saugy M; Mangin P
    Clin Lab; 2003; 49(1-2):57-62. PubMed ID: 12593476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin solution: a potential oxygen transporting plasma volume expander.
    Kaplan HR; Murthy VS
    Fed Proc; 1975 May; 34(6):1461-5. PubMed ID: 1126443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin use and abuse: When physiology and pharmacology collide.
    Spivak JL
    Adv Exp Med Biol; 2001; 502():207-24. PubMed ID: 11950139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin concentration in developing harbor seals (Phoca vitulina).
    Clark CA; Burns JM; Schreer JF; Hammill MO
    Gen Comp Endocrinol; 2006 Jul; 147(3):262-7. PubMed ID: 16500652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary and cardiovascular dynamics and oxygen availability during acute normovolemic anemia.
    Geha AS
    Surgery; 1976 Jul; 80(1):47-53. PubMed ID: 1273767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances].
    Scheen AJ
    Rev Med Liege; 1998 Aug; 53(8):499-502. PubMed ID: 9810213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of alterations in total hemoglobin mass on VO 2max.
    Schmidt W; Prommer N
    Exerc Sport Sci Rev; 2010 Apr; 38(2):68-75. PubMed ID: 20335738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal ontogeny of erythropoietin and hematology in free-ranging Steller sea lions (Eumetopias jubatus).
    Richmond JP; Burns JM; Rea LD; Mashburn KL
    Gen Comp Endocrinol; 2005 May; 141(3):240-7. PubMed ID: 15804511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.